Finance

Beta
Lists
COPN:SWX
Cosmo Pharmaceuticals NV
CHF 72.80
-1.49%
(-1.10) 1D
Jun 5, 5:30:12 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for COPN...
Open
CHF 74.10
High
CHF 74.60
Low
CHF 72.80
Mkt. cap
1.30B
Avg. vol.
42.67K
Volume
15.38K
Dividend
2.65%
Quarterly dividend
CHF 0.48
Ex-dividend date
Apr 24, 2026
52-wk high
CHF 129.40
52-wk low
CHF 53.40
EPS
-CHF 0.21
Shares outstanding
17.54M
No. of employees
325
Open
CHF 74.10
High
CHF 74.60
Low
CHF 72.80
Mkt. cap
1.30B
Avg. vol.
42.67K
Volume
15.38K
Dividend
2.65%
Quarterly dividend
CHF 0.48
Ex-dividend date
Apr 24, 2026
52-wk high
CHF 129.40
52-wk low
CHF 53.40
EPS
-CHF 0.21
Shares outstanding
17.54M
No. of employees
325
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to COPN in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for COPN in the last 3 months.
Highest
Current CHF 72.80
CHF 160.00 (+119.78%)
Average
CHF 143.33 (+96.88%)
Lowest
CHF 130.00 (+78.57%)
News stories
From sources across the web
About Cosmo Pharmaceuticals NV
CEO-
Employees325
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
25.86M
25.86M
26.23M
26.23M
Cost of goods sold
12.79M
12.79M
14.02M
14.02M
Cost of revenue
12.79M
12.79M
14.02M
14.02M
Research and development expenses
9.00M
9.00M
8.09M
8.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.13M
7.13M
6.27M
6.27M
Operating expense
13.78M
13.78M
14.97M
14.97M
Total operating expenses
26.57M
26.57M
28.99M
28.99M
Operating income
-705.50K
-705.50K
-2.76M
-2.76M
Other non operating income
-17.50K
-17.50K
-13.00K
-13.00K
EBT including unusual items
-335.00K
-335.00K
-124.00K
-124.00K
EBT excluding unusual items
-1.55M
-1.55M
-916.00K
-916.00K
Income tax expense
680.00K
680.00K
606.00K
606.00K
Effective tax rate
-202.99%
-202.99%
-488.71%
-488.71%
Other operating expenses
-2.35M
-2.35M
611.00K
611.00K
Net income
-1.00M
-1.00M
-801.00K
-801.00K
Net profit margin
-3.88%
-3.88%
-3.05%
-3.05%
Earnings per share
-
-
-
-
Interest and investment income
360.50K
360.50K
2.02M
2.02M
Interest expense
-31.50K
-31.50K
-28.50K
-28.50K
Net interest expenses
329.00K
329.00K
1.99M
1.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.43M
2.43M
104.50K
104.50K
Gain or loss from assets sale
-
-
13.00K
13.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more